Proton Pump Inhibitor Switching Strategy after Failure of Standard Triple Therapy for Infection
Background/Aims It is still unknown whether cytochrome P450 (CYP) 2C19 polymorphisms influence Helicobacter pylori (H. pylori) eradication, especially in eastern Asia. We aimed to evaluate how changes in proton pump inhibitor (PPI) strategies could be used to overcome the effects of CYP2C19 polymorp...
Main Authors: | Jaeyoung Kim, Yeon-Ji Kim, Woo Chul Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Yong Chan Lee
2020-06-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Subjects: | |
Online Access: | http://www.helicojournal.org/upload/pdf/kjhugr-2019-0036.pdf |
Similar Items
-
Standard First-line Triple Therapy for Helicobacter pylori Infection: A Comparison of Eradication Rates Based on Timing of Administration of Proton Pump Inhibitors
by: Seong Ju Lee, et al.
Published: (2018-06-01) -
Pharmacogenetics of proton pump inhibitors
by: M. V. Leonova
Published: (2015-12-01) -
Efficacy of Low Dose Proton Pump Inhibitor-Based Therapy to Eradicate <i>Helicobacter pylori</i> in Patients with Subtotal Gastrectomy
by: Dongwoo Kim, et al.
Published: (2019-11-01) -
Rational PPI therapy: risks and benefits of prolonged use of proton pump inhibitors in the updated recommendations of experts of the American Gastroenterological Association
by: Yu.M. Stepanov
Published: (2017-04-01) -
Efficacy of Seven-day High-dose Esomeprazole-based Triple Therapy versus Seven-day Standard Dose Non-esomeprazole-based Triple Therapy as the First-line Treatment of Patients with Helicobacter pylori Infection
by: Young Dal Lee, et al.
Published: (2020-09-01)